Related references
Note: Only part of the references are listed.Matrix Metalloproteinase-8 is a Novel Pathogenetic Factor in Focal Cerebral Ischemia
Jeong Eun Han et al.
MOLECULAR NEUROBIOLOGY (2016)
Brain-derived neurotrophic factor regulates cell motility in human colon cancer
Ssu-Ming Huang et al.
ENDOCRINE-RELATED CANCER (2015)
Compound 21 is pro-angiogenic in the brain and results in sustained recovery after ischemic stroke
Ahmed Alhusban et al.
JOURNAL OF HYPERTENSION (2015)
Low-Dose Candesartan Enhances Molecular Mediators of Neuroplasticity and Subsequent Functional Recovery After Ischemic Stroke in Rats
Tauheed Ishrat et al.
MOLECULAR NEUROBIOLOGY (2015)
Lingo-1 Inhibited by RNA Interference Promotes Functional Recovery of Experimental Autoimmune Encephalomyelitis
Chun-Juan Wang et al.
ANATOMICAL RECORD-ADVANCES IN INTEGRATIVE ANATOMY AND EVOLUTIONARY BIOLOGY (2014)
Cerebral neovascularization in diabetes: implications for stroke recovery and beyond
Adviye Ergul et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2014)
Image-guided Pro-angiogenic Therapy in Diabetic Stroke Mouse Models Using a Multi-modal Nanoprobe
Ying-Ying Bai et al.
THERANOSTICS (2014)
Lentiviral Vector-Mediated RNA Silencing in the Central Nervous System
Thomas H. Hutson et al.
HUMAN GENE THERAPY METHODS (2014)
Candesartan Induces a Prolonged Proangiogenic Effect and Augments Endothelium-Mediated Neuroprotection after Oxygen and Glucose Deprivation: Role of Vascular Endothelial Growth Factors A and B
Sahar Soliman et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2014)
The role of Homer 1a in increasing locomotor activity and non-selective attention, and impairing learning and memory abilities
Lei Yang et al.
BRAIN RESEARCH (2013)
Telmisartan attenuates MPTP induced dopaminergic degeneration and motor dysfunction through regulation of α-synuclein and neurotrophic factors (BDNF and GDNF) expression in C57BL/6J mice
Sekar Sathiya et al.
NEUROPHARMACOLOGY (2013)
Local Administration of AAV-BDNF to Subventricular Zone Induces Functional Recovery in Stroke Rats
Seong-Jin Yu et al.
PLOS ONE (2013)
Serum Brain-Derived Neurotrophic Factor and Vascular Endothelial Growth Factor Levels Are Associated With Risk of Stroke and Vascular Brain Injury Framingham Study
Aleksandra Pikula et al.
STROKE (2013)
AT1 Receptor Antagonism Is Proangiogenic in the Brain: BDNF a Novel Mediator
Ahmed Alhusban et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2013)
Neuronal regeneration and protection by collagen-binding BDNF in the rat middle cerebral artery occlusion model
Jian Guan et al.
BIOMATERIALS (2012)
Telmisartan protects against cognitive decline via up-regulation of brain-derived neurotrophic factor/tropomyosin-related kinase B in hippocampus of hypertensive rats
Takuya Kishi et al.
JOURNAL OF CARDIOLOGY (2012)
Promoting brain remodelling and plasticity for stroke recovery: therapeutic promise and potential pitfalls of clinical translation
Dirk M. Hermann et al.
LANCET NEUROLOGY (2012)
Angiogenesis A Harmonized Target for Recovery After Stroke
Adviye Ergul et al.
STROKE (2012)
Molecular mechanisms and clinical applications of angiogenesis
Peter Carmeliet et al.
NATURE (2011)
Potential therapeutic uses of BDNF in neurological and psychiatric disorders
Alan H. Nagahara et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
Vascular Protection by Angiotensin Receptor Antagonism Involves Differential VEGF Expression in Both Hemispheres after Experimental Stroke
Weihua Guan et al.
PLOS ONE (2011)
Lentiviral shRNA silencing of BDNF inhibits in vivo multiple myeloma growth and angiogenesis via down-regulated stroma-derived VEGF expression in the bone marrow milieu
Lu Zhang et al.
CANCER SCIENCE (2010)
Human Neural Stem Cells Genetically Modified To Overexpress Brain-Derived Neurotrophic Factor Promote Functional Recovery and Neuroprotection in a Mouse Stroke Model
Hong J. Lee et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2010)
Knockdown of brain-derived neurotrophic factor in specific brain sites precipitates behaviors associated with depression and reduces neurogenesis
D. Taliaz et al.
MOLECULAR PSYCHIATRY (2010)
New insights into the role of brain-derived neurotrophic factor in synaptic plasticity
Emily G. Waterhouse et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2009)
Cardiovascular Actions of Neurotrophins
Andrea Caporali et al.
PHYSIOLOGICAL REVIEWS (2009)
Candesartan Augments Ischemia-Induced Proangiogenic State and Results in Sustained Improvement After Stroke
Anna Kozak et al.
STROKE (2009)
Brain-Derived Neurotrophic Factor Contributes to Recovery of Skilled Reaching After Focal Ischemia in Rats
Michelle Ploughman et al.
STROKE (2009)
Targeting Neurotrophin Receptors in the Central Nervous System
Italo Mocchetti et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2008)
Applications of Lentiviral Vectors for shRNA Delivery and Transgenesis
Oded Singer et al.
CURRENT GENE THERAPY (2008)
Candesartan but not ramipril pretreatment improves outcome after stroke and stimulates neurotrophin BNDF/TrkB system in rats
Maxim Krikov et al.
JOURNAL OF HYPERTENSION (2008)
Brain-derived neurotrophic factor but not forced arm use improves long-term outcome after photothrombotic stroke and transiently upregulates binding densities of excitatory glutamate receptors in the rat brain
Harald D. Mueller et al.
STROKE (2008)
Intravenous brain-derived neurotrophic factor enhances poststroke sensorimotor recovery and stimulates neurogenesis
Wolf-Ruediger Schaebitz et al.
STROKE (2007)
Brain-derived neurotrophic factor: A newly described mediator of angiogenesis
Pouneh Kermani et al.
TRENDS IN CARDIOVASCULAR MEDICINE (2007)
Blood-brain barrier targeting of BDNF improves motor function in rats with middle cerebral artery occlusion
Yun Zhang et al.
BRAIN RESEARCH (2006)
Comparison of inhibitory action of candesartan and enalapril on brain ischemia through inhibition of oxidative stress
Meiko Hamai et al.
NEUROPHARMACOLOGY (2006)
Decreased expression of brain-derived neurotrophic factor in BDNF+/- mice is associated with enhanced recovery of motor performance and increased neuroblast number following experimental stroke
Josefine Nygren et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2006)
Hypertension after experimental cerebral ischemia: candesartan provides neurovascular protection
SC Fagan et al.
JOURNAL OF HYPERTENSION (2006)
Exercise differentially regulates synaptic proteins associated to the function of BDNF
SS Vaynman et al.
BRAIN RESEARCH (2006)
Sustained blockade of brain AT1 receptors before and after focal cerebral ischemia alleviates neurologic deficits and reduces neuronal injury, apoptosis, and inflammatory responses in the rat
M Lou et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2004)
Effect of brain-derived neurotrophic factor treatment and forced arm use on functional motor recovery after small cortical ischemia
WR Schäbitz et al.
STROKE (2004)
The angiotensin II type 1-receptor blocker candesartan increases cerebral blood flow, reduces infarct size, and improves neurologic outcome after transient cerebral ischemia in rats
T Engelhorn et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2004)
Intravenous administration of marrow stromal cells (MSCs) increases the expression of growth factors in rat brain after traumatic brain injury
A Mahmood et al.
JOURNAL OF NEUROTRAUMA (2004)
Exercise induces BDNF and synapsin I to specific hippocampal subfields
S Vaynman et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2004)
Normalization of endothelial and inducible nitric oxide synthase expression in brain microvessels of spontaneously hypertensive rats by angiotensin II AT1 receptor inhibition
H Yamakawa et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2003)
Protection against ischemia and improvement of cerebral blood flow in genetically hypertensive rats by chronic pretreatment with an angiotensin II AT1 antagonist
T Ito et al.
STROKE (2002)
Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack (Vol 358, pg 1033, 2001)
LANCET (2001)
Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack
S MacMahon et al.
LANCET (2001)